The LongeVC investment group has announced that it is launching a proprietary acceleration program. The group is using the opportunity to invite professionals with backgrounds and experience in the biotech industry to join, with the aim being the creation of highly qualified teams of startups. LongeVC is convinced that the creation of such working groups would allow the industry to better solve existing challenges. All applications for participation in the program will be accepted on a rolling basis.
'This is a unique approach that we have developed, as it is uncommon in venture capital practice. We have our own accelerator program and that means we will be able to define verticals for catering to existing potential. Our program provides both mentoring and assistance to ensure a high quality makeup of each startup,' as stated by LongeVC Fund Partner Sergey Jakimov.
All those willing to participate in the program will have to fill out a simple form available on the official LongeVC website at https://longevc.com/#acceleration and state their relevant expertise. The management of LongeVC is also highlighting the fact that previous experience is not as important as the possibility of combining professionals in a team with different levels of skill and knowledge.
'We are confident that the next unicorn in the longevity industry will be developed from scratch. We have extensive experience in identifying and supporting startups that we believe have the potential to grow. But it all starts from bringing together brilliant professionals who can be oriented at a goal, such as inventing a groundbreaking technology. As such, we welcome startup founders and professionals in the biotech and longevity industries to join our program and grow together,' Jakimov adds.
LongeVC is aiming at continuing its search for promising startups at the seed and early A stages in the biotech industry. The management team of the fund is ready and willing to provide support to startups that have working MVP concepts and business models.
'So many promising projects on the market are not getting any of the necessary assistance and support that would give them a chance to develop. We aim to identify and onboard promising startups from the get-go. That is why we developed this accelerator program. We are primarily focused on AI applications for drug discovery and predictive diagnostics. Teams working in such areas require a lot of support and, most importantly - access to industry datasets to ensure quality product development and to remain on par with market progress,' states Rustam Gilfanov, LongeVC Venture Partner, private investor, and philanthropist.
The LongeVC fund has access to over 35 million Euros in funding, which will be directed at seed and pre-A seed funding stage startups. Given that companies at such stages have limited access to funds and belief in their success, LongeVC will be focusing on startups working on solutions in the biotech and longevity sectors to provide them with the necessary levels of support. The fund already has world-class experts in the field on board who are willing to assist startups as advisors. Among the advisors collaborating with LongeVC is one of the leading anti-aging specialists in the world-renowned gerontologist and PhD holder from the University of Cambridge, author of more than 290 publications Aubrey De Grey, founder of Deep Longevity, Inc. and Adjunct Professor at the Buck Institute for Research on Aging Alex Zhavoronkov (PhD), and other experts.
The LongeVC investment group specializes in mentoring and assisting startups at early stages with venture investments in the biotech and longevity industries. The fund's current portfolio includes such companies as Insilico Medicine, a global leader in AI-driven drug discovery, Longenesis, an end-to-end collaborative biotech research enabler, Basepaws, the first comprehensive DNA sequencing solution for pets, as well as other biotech industry-specific companies. LongeVC has recently created a biotech and longevity-oriented fund aimed at supporting promising companies in the given fields. The fund also has an advisory board consisting of industry experts to assist startups selected for participation in the acceleration program.